Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Platelet activation and blood coagulation in atherothrombosis

International Aspirin Foundation Meeting

Published: 29 Jan 2020

Views: 583

Rating:

Save

Prof Lina Badimon - Cardiovascular Research Center, Barcelona, Spain

Prof Lina Badimon speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the implications of platelet activation and blood coagulation in atherothrombosis.

Prof Badimon outlines the increased research in understanding the complications of platelet activation and blood coagulation in atherothrombosis.

Following this, she provides relevant advice for clinicians to take into everyday practise.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.

Related Videos

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale...

ESMO and WCLC: Latest developments in EGFR mutated NSCLC ( Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale Tomasini )

Encouraging results using mismatched unrelated donors in stem cell...

Dr Monzr Al Malki and Dr Steven Devine

Encouraging results using mismatched unrelated donors in stem cell transplantation ( Dr Monzr Al Malki and Dr Steven Devine )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA...

Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer...

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours ( Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK )

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non...

Prof Peter Szlosarek - Barts Cancer Institute, London, UK

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma ( Prof Peter Szlosarek - Barts Cancer Institute, London, UK )

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR...

Prof Nicolas Girard - Institut Curie, Paris, France

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Four chemo cycles given with durvalumab and tremelimumab optimise response and...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in...

Dr Laurence Albiges - Institut Gustave Roussy, Villejuif, France

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced RCC ( Dr Laurence Albiges - Institut Gustave Roussy, Villejuif, France )

Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

More from ecancer